Combination of Circulating Cell-Free DNA and Positron Emission Tomography to Distinguish Non–Small Cell Lung Cancer from Tuberculosis
Laboratory Medicine · 07.03.2023 · 54 (2) · 130-141
DOI: 10.1093/labmed/lmac085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laboratory Medicine, online erschienen am 15.09.2022. Verfasst von Wenqiang Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, First Affiliated Hospital of Wannan Medical College, Wuhu, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Cell-Free Nucleic Acids, Tuberculosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Natural Science Research Project of Anhui Colleges and Universities, Wannan Medical College.
Abstract (Originalsprache)
Objective
Non–small cell lung cancer (NSCLC) holds high metabolic tumor burden and circulating cell-free DNA (cfDNA) levels, and the relationship between metabolic tumor burden and cfDNA in NSCLC and the underlying mechanism of their interaction therein remain poorly characterized. Our aim was to evaluate the clinical value of cfDNA and metabolic tumor burden by positron emission tomography-computed tomography (PET/CT) for NSCLC differential diagnosis from tuberculosis in patients with solitary pulmonary nodules.
Methods
Metabolic tumor burden values in humans (subjects with NSCLC, subjects with tuberculosis, and healthy control subjects) and relevant mouse models were detected by preoperative 18F-fluorodeoxyglucose PET (18F-FDG PET/CT) and [3H]-2-deoxy-DG uptake, respectively. The cfDNA levels were detected by quantifying serum cfDNA fragments from the ALU (115 bp) gene using reverse transcription–polymerase chain reaction. RNA sequence was performed to determine the underlying target genes and knocked down or inhibited the target genes in vivo and in vitro to determine the mechanism therein.
Results
Metabolic tumor burden correlated with serum cfDNA levels in NSCLC subjects but not in tuberculosis subjects or healthy controls. Mouse models showed a similar phenomenon. In addition, the RNA sequence showed that glucose transporter 1 (GLU1), factor-related apoptosis ligand (FasL), caspase 8, and caspase 3 were significantly increased in NSCLC mouse tumors compared with those in tuberculosis mouse masses. Inhibiting the metabolic tumor burden by blocking or knocking down GLU1 markedly reduced the expression of FasL, the phosphorylation of caspase 8/caspase 3, and serum cfDNA levels/apoptosis percentage in vivo and in vitro. Furthermore, the use of a combination of cfDNA and metabolic tumor burden allowed better ability to distinguish NSCLC subjects from those with tuberculosis or healthy controls than either method used alone.
Conclusion
Metabolic tumor burden promotes the formation of circulating cfDNA through GLU1-mediated apoptosis in NSCLC, and the combination of cfDNA and metabolic tumor burden could be valuable for distinguishing NSCLC from tuberculosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, First Affiliated Hospital of Wannan Medical College, Wuhu, China.
- Department of Infectious Diseases, First Affiliated Hospital of Wannan Medical College, Wuhu, China.
- Department of Clinical Laboratory, Second Affiliated Hospital of Wannan Medical College, Wuhu, China.
- Department of Clinical Laboratory, First Affiliated Hospital of Wannan Medical College, Wuhu, China.
Förderung
- Natural Science Research Project of Anhui Colleges and Universities
- Wannan Medical College
Zitieren
APA
Zheng, W., Quan, B., Gao, G., Zhang, P., & Huang, L. (2023). Combination of Circulating Cell-Free DNA and Positron Emission Tomography to Distinguish Non–Small Cell Lung Cancer from Tuberculosis. Laboratory Medicine, 54(2), 130-141. https://doi.org/10.1093/labmed/lmac085
Vancouver
Zheng W, Quan B, Gao G, Zhang P, Huang L. Combination of Circulating Cell-Free DNA and Positron Emission Tomography to Distinguish Non–Small Cell Lung Cancer from Tuberculosis. Laboratory Medicine. 2023;54(2):130-141. doi:10.1093/labmed/lmac085
BibTeX
@article{Zheng2023,
author = {Zheng, Wenqiang and Quan, Bin and Gao, Guangjian and Zhang, Puhong and Huang, Lizhu},
title = {Combination of Circulating Cell-Free DNA and Positron Emission Tomography to Distinguish Non–Small Cell Lung Cancer from Tuberculosis},
journal = {Laboratory Medicine},
year = {2023},
volume = {54},
number = {2},
pages = {130--141},
doi = {10.1093/labmed/lmac085}
}
EUVIMED